Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus

被引:8
|
作者
Crisman, Celina M. [1 ]
Patel, Ankur R. [2 ,3 ]
Winston, Graham [4 ]
Brennan, Cameron W. [2 ,3 ]
Tabar, Viviane [2 ,3 ]
Moss, Nelson S. [2 ,3 ]
机构
[1] UMass Mem Med Ctr, Dept Neurosurg, Worcester, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Brain Metastasis Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, New York, NY USA
基金
美国国家卫生研究院;
关键词
Choroid plexus; Intraventricular metastasis; Renal cell carcinoma; Stereotactic body radiotherapy; Stereotactic radiosurgery; BRAIN METASTASES; PROGNOSTIC-FACTORS; SURVIVAL; RADIOSURGERY; THERAPY;
D O I
10.1016/j.wneu.2020.03.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Intraventricular metastatic brain tumors account for a small, but challenging, fraction of metastatic brain tumors (0.9%-4.5%). Metastases from renal cell carcinoma (RCC) account for a large portion of these intraventricular tumors. Although patient outcomes have been assumed to be poor, these have not been reported in a modern series with a multimodality treatment paradigm of radiotherapy (RT), resection, and cerebrospinal fluid (CSF) diversion. We have presented the first case series of patients with intraventricular metastatic tumors from RCC. METHODS: We performed a single-institution retrospective review of patients with intraventricular RCC metastases treated from January 2003 to January 2019. Volumetric analysis was used to delineate the tumor size and the Kaplan-Meier method to evaluate the survival data. RESULTS: A total of 22 intraventricular RCC metastases were identified in 19 patients with 61.3 patient-years of follow-up. The median patient age was 64 years, and the median tumor volume was 2.2 cm(3). Overall, 19 metastases had been treated initially with RT. Of these, 16 had received stereotactic body RT and 3 had received whole brain RT. Three tumors were surgically excised and had received adjuvant stereotactic body RT in the upfront setting. Although 5 patients had presented with obstructive hydrocephalus, none had required CSF diversion. After treatment, 5 metastases had progressed, resulting in 1- and 3-year progression-free survival rates of 81.6% and 68%, respectively. The median overall survival was 2.8 years, with 1- and 5-year overall survival rates of 76.7% and 28.3%, respectively. Leptomeningeal carcinomatosis was not observed. CONCLUSIONS: Despite the relatively limited overall survival for this population with metastatic cancer, comparable to contemporary parenchymal brain metastasis cohorts, reasonable local central nervous system control was achieved in most patients using a paradigm of focal RT and resection, where indicated. Finally, CSF diversion was not required even in patients presenting with hydrocephalus.
引用
收藏
页码:E7 / E13
页数:7
相关论文
共 50 条
  • [31] Successful therapy of choroid plexus carcinoma
    Strojan, P
    Jereb, B
    Popovic, M
    Surlan, K
    PEDIATRIC BLOOD & CANCER, 2004, 43 (02) : 179 - 179
  • [32] A choroid plexus metastasis of a prostatic adenocarcinoma mimicking a choroid plexus carcinoma: A case report
    Sellier, A.
    Russo, D.
    Robertson, F. C.
    Rodriguez-Arribas, M-A
    Charissoux, M.
    Azria, D.
    Boetto, J.
    NEUROCHIRURGIE, 2022, 68 (01) : 113 - 116
  • [33] Late recurrence of choroid plexus carcinoma
    Hart, Shannon
    Avery, Roger
    Barron, Jane
    CHILDS NERVOUS SYSTEM, 2020, 36 (08) : 1601 - 1606
  • [34] Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma
    Yasuda, Yosuke
    Fujii, Yasuhisa
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Urakami, Shinji
    Yamamoto, Shinya
    Yonese, Junji
    Takahashi, Shunji
    Fukui, Iwao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 877 - 883
  • [35] Do renal cell carcinoma patients with brain metastases still need nephrectomy?
    Zhuang, Wei
    Li, Yining
    Chen, Panyu
    Wang, Jialiang
    Liu, Weihui
    Chen, Jiabi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (06) : 941 - 949
  • [36] Do renal cell carcinoma patients with brain metastases still need nephrectomy?
    Wei Zhuang
    Yining Li
    Panyu Chen
    Jialiang Wang
    Weihui Liu
    Jiabi Chen
    International Urology and Nephrology, 2019, 51 : 941 - 949
  • [37] STEREOTACTIC RADIOSURGICAL TREATMENT OF BRAIN METASTASES TO THE CHOROID PLEXUS
    Siomin, Vitaly
    Lin, Jennifer L.
    Marko, Nicholas F.
    Barnett, Gene H.
    Toms, Steven A.
    Chao, Samuel T.
    Angelov, Lilyana
    Vogelbaum, Michael A.
    Navaratne, Kapila
    Suh, John H.
    Weil, Robert J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 1134 - 1142
  • [38] Outcomes of patients with spinal metastases from renal cell carcinoma treated with conventionally-fractionated external beam radiation therapy
    Lee, Chia Ching
    Tey, Jeremy Chee Seong
    Cheo, Timothy
    Lee, Chau Hung
    Wong, Alvin
    Kumar, Naresh
    Vellayappan, Balamurugan
    MEDICINE, 2020, 99 (16) : E19838
  • [39] Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era The University of Rochester Experience
    Bates, James E.
    Youn, Paul
    Peterson, Carl R.
    Usuki, Kenneth Y.
    Walter, Kevin A.
    Okunieff, Paul
    Milano, Michael T.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 439 - 443
  • [40] Clinical Characteristics and Prognosis of Renal Cell Carcinoma With Spinal Bone Metastases
    Zhai, Jianpo
    Liu, Ning
    Wang, Hai
    Huang, Guanglin
    Man, Libo
    FRONTIERS IN ONCOLOGY, 2021, 11